Anaphylaxis is a serious allergic reaction that has the potential to be life-threatening, but there is emergency treatment. Join us to learn why epinephrine is the first-line treatment for anaphylaxis, and what role, if any, antihistamines have during a reaction. Plus, build your confidence in learning how to recognize anaphylaxis and what to do in case you or someone you know experiences it.
What the webinar is about: The importance of using epinephrine for treatment of anaphylaxis and when antihistamines might be given, along with a review of the signs and symptoms of anaphylaxis and the possibility of biphasic or secondary reactions. There will also be a discussion on what the common concerns are in using epinephrine and what can be done to overcome them. This will be followed by a Q&A, where you can ask your questions. Plus, you can submit your questions in advance upon registration.
Dr. Wade Watson
Who is presenting: Dr. Wade Watson, Professor of Pediatrics, Dalhousie University, Head of the Division of Allergy, IWK Health Centre, and Chair of the Specialty Committee, Clinical Immunology and Allergy, Royal College of Physicians and Surgeons of Canada. Dr. Watson is also a member of our Healthcare Advisory Board.
When is the webinar: Wednesday, May 19, 2021 from 12pm–1pm EDT.
Don’t miss out, register now and share with others who may benefit from the session!
Obtenez des renseignements essentiels sur les allergies directement dans votre boîte de réception
